AUCTORES
Globalize your Research
Research Article | DOI: https://doi.org/10.31579/2640-1053/153
1WHO Project Manger
2GLSBOR Elected President
*Corresponding Author: Abdalla Abotaleb, WHO Project Manger GLSBOR Elected President.
Citation: Abdalla Abotaleb (2023), Challenges for Accessibility of Blood Derivatives products in Egypt, J Cancer Research and Cellular Therapeutics, 7(3); DOI:10.31579/2640-1053/153
Copyright: © 2023, Lizaveta I. Bon. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received: 26 June 2023 | Accepted: 07 July 2023 | Published: 18 July 2023
Keywords: blood derivatives accepility; Egypt; abdalla abotaleb
Background
Haigh population with low middle income for a country like Egypt might Create a challenge on Health care system resources and affect on Priorization of health system needs. With critical products like blood derivatives several elements might affect accessibility for these products.
The objective for this research is analyzing from policy perspective these elements in order to enhance Accepility for the patients which will lead to System Enhancement
Methods
Integration between survey Analysis for 125 of Health care professionals in Egypt Including (Physicians, Pharmacists, Supply chain Managers and payers) plus stock and sales analysis for previous 5 years. One way sensitivity analysis was conducted for robustness of data guaranteeing
Results
The following Results were fended.
Localization of Blood Derivatives manufacturing Process might enhance Accepility through Controlling of Prices plus availability enhancement which will lead to Resources utilization
Haigh population with low middle income for a country like Egypt might Create a challenge on Health care system resources and affect on
Priorization of health system needs. With critical products like blood derivatives several elements might affect accessibility for these products.
The objective for this research is analyzing from policy prospective these elements in order to enhance Accepility for the patients which will lead to System Enhancement
Figure 1: Regional distribution of population and blood donations by WHO region and World Bank income group, 2013
Figure 2: Jean Sterne, a French physician (1909-1997)
Figure 3: Middle East and Africa Artificial Blood Substitutes Market is Expected
Figure 4: Number of Blood Centers in the country
Figure 5: Number of whole blood donations collected
Figure 6: Proportions of voluntary non-remunerated whole blood donations by WHO region and World Bank income group, 2013
Figure 7: The World-Wide Plasma Products Market - 2020 By Region
Integration between survey Analysis for 125 of Health care professionals in Egypt Including (Physicians, Pharmacists, Supply chain Managers and payers) plus stock and sales analysis for previous 5 years. One way sensitivity analysis was conducted for robustness of data guaranteeing
The following Results were fended
Figure 8: Albumine Case
Figure 9: IVIG Case
Localization of Blood Derivatives manufacturing Process might enhance Accepility through Controlling of Prices plus availability enhancement which will lead to Resources utilization